Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05298254 |
|---|---|
| Brief Title: | A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes |
| First Submitted : | March 4, 2022 |
| First Submitted that Met QC Criteria : | March 25, 2022 |
| First Posted : | March 28, 2022 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |